Targeted therapy in severe asthma today: focus on immunoglobulin E

Targeted therapy in severe asthma today: focus on immunoglobulin E

Girolamo Pelaia,1 Giorgio Walter Canonica,2 Andrea Matucci,3 Rossella Paolini,4 Massimo Triggiani,5 Pierluigi Paggiaro6 1Department of Medical and Surgical Sciences, Section of Respiratory Diseases, University Magna Graecia of Catanzaro, Catanzaro, 2Personalized Medicine Asthma & Allergy Cl...

Full description

Bibliographic Details
Main Authors: Pelaia G, Canonica GW, Matucci A, Paolini R, Triggiani M, Paggiaro P
Format: Article
Language:English
Published: Dove Medical Press 2017-06-01
Series:Drug Design, Development and Therapy
Subjects:
anti-immunoglobulin E
allergic asthma
Global Initiative for Asthma step 5 therapy
severe persistent asthma
omalizumab
phenotypes
targeted therapy
Online Access:https://www.dovepress.com/targeted-therapy-in-severe-asthma-today-focus-on-immunoglobulin-e-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/targeted-therapy-in-severe-asthma-today-focus-on-immunoglobulin-e-peer-reviewed-article-DDDT

Similar Items